Literature DB >> 9105197

Major depression: selecting safe and effective treatment.

S C Bhatia1, S K Bhatia.   

Abstract

Diagnosis and management of major depression, a condition that is frequently encountered by primary care physicians, must take into account such factors as the patient's age, comorbid conditions and specific presenting symptoms. Rational selection of antidepressant medication must also include analysis of potential side effects and drug-drug or drug-food interactions. Psychiatric consultation may benefit a select group of patients. Although some patients may require life-long antidepressant medication, most will be able to discontinue their medication after a period of time. Newer antidepressants are expanding the treatment options available to family physicians.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9105197

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  4 in total

1.  Can selective serotonin inhibitor drugs in elderly patients in nursing homes be reduced?

Authors:  Kjell Lindström; Anders Ekedahl; Anders Carlsten; Jan Mårtensson; Sigvard Mölstad
Journal:  Scand J Prim Health Care       Date:  2007-03       Impact factor: 2.581

2.  Controlled withdrawal of selective serotonin reuptake inhibitor drugs in elderly patients in nursing homes with no indication of depression.

Authors:  Johanna Ulfvarson; Johanna Adami; Regina Wredling; Bengt Kjellman; Marie Reilly; Christer von Bahr
Journal:  Eur J Clin Pharmacol       Date:  2003-11-01       Impact factor: 2.953

3.  National Patterns of Medication Treatment for Depression, 1987 to 2001.

Authors:  Randall S. Stafford; Ellen A. MacDonald; Stan N. Finkelstein
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-12

4.  Effectiveness of screening and treatment for depression in ambulatory indigent patients.

Authors:  David Jarjoura; Ann Polen; Elizabeth Baum; Denize Kropp; Suzanne Hetrick; Gregory Rutecki
Journal:  J Gen Intern Med       Date:  2004-01       Impact factor: 5.128

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.